Literature DB >> 33084550

Oral contraceptive use and risk of suicidal behavior among young women.

Alexis C Edwards1, Sara Larsson Lönn2, Casey Crump3,4, Eve K Mościcki, Jan Sundquist2,3,4, Kenneth S Kendler1, Kristina Sundquist2,3,4.   

Abstract

BACKGROUND: Oral contraceptive use has been previously associated with an increased risk of suicidal behavior in some, but not all, samples. The use of large, representative, longitudinally-assessed samples may clarify the nature of this potential association.
METHODS: We used Swedish national registries to identify women born between 1991 and 1995 (N = 216 702) and determine whether they retrieved prescriptions for oral contraceptives. We used Cox proportional hazards models to test the association between contraceptive use and first observed suicidal event (suicide attempt or death) from age 15 until the end of follow-up in 2014 (maximum age 22.4). We adjusted for covariates, including mental illness and parental history of suicide.
RESULTS: In a crude model, use of combination or progestin-only oral contraceptives was positively associated with suicidal behavior, with hazard ratios (HRs) of 1.73-2.78 after 1 month of use, and 1.25-1.82 after 1 year of use. Accounting for sociodemographic, parental, and psychiatric variables attenuated these associations, and risks declined with increasing duration of use: adjusted HRs ranged from 1.56 to 2.13 1 month beyond the initiation of use, and from 1.19 to 1.48 1 year after initiation of use. HRs were higher among women who ceased use during the observation period.
CONCLUSIONS: Young women using oral contraceptives may be at increased risk of suicidal behavior, but risk declines with increased duration of use. Analysis of former users suggests that women susceptible to depression/anxiety are more likely to cease hormonal contraceptive use. Additional studies are necessary to determine whether the observed association is attributable to a causal mechanism.

Entities:  

Keywords:  Cohort study; oral contraception; registry data; suicidal behavior

Mesh:

Substances:

Year:  2020        PMID: 33084550      PMCID: PMC8917871          DOI: 10.1017/S0033291720003475

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   10.592


  4 in total

1.  An Update on Contraception in Polycystic Ovary Syndrome.

Authors:  Seda Hanife Oguz; Bulent Okan Yildiz
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-15

2.  Associations between use of psychotropic medications and use of hormonal contraception among girls and women aged 15-49 years in Finland: a nationwide, register-based, matched case-control study.

Authors:  Elena Toffol; Timo Partonen; Oskari Heikinheimo; Anna But; Antti Latvala; Jari Haukka
Journal:  BMJ Open       Date:  2022-02-22       Impact factor: 2.692

3.  The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study.

Authors:  Søren Vinther Larsen; Brice Ozenne; Kristin Köhler-Forsberg; Asbjørn Seenithamby Poulsen; Vibeke Høyrup Dam; Claus Svarer; Gitte Moos Knudsen; Martin Balslev Jørgensen; Vibe Gedso Frokjaer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-11       Impact factor: 5.555

4.  Duration of oral contraceptive use relates to cognitive performance and brain activation in current and past users.

Authors:  Isabel Asar Noachtar; Esmeralda Hidalgo-Lopez; Belinda Pletzer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.